☰

Justin D. Oh, Ph.D. - Publications

Affiliations: 
Central Michigan University Central Michigan University, Mount Pleasant, MI, United States 
Area:
Parkinson\'s disease
Tree Info Grants Similar researchers PubMed Report error

22 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2007 Smith CP, Oh JD, Bibbiani F, Collins MA, Avila I, Chase TN. Tamoxifen effect on L-DOPA induced response complications in parkinsonian rats and primates. Neuropharmacology. 52: 515-26. PMID 17116309 DOI: 10.1016/J.Neuropharm.2006.08.018  0.582
2005 Bibbiani F, Oh JD, Kielaite A, Collins MA, Smith C, Chase TN. Combined blockade of AMPA and NMDA glutamate receptors reduces levodopa-induced motor complications in animal models of PD. Experimental Neurology. 196: 422-9. PMID 16203001 DOI: 10.1016/J.Expneurol.2005.08.017  0.67
2004 Wessell RH, Ahmed SM, Menniti FS, Dunbar GL, Chase TN, Oh JD. NR2B selective NMDA receptor antagonist CP-101,606 prevents levodopa-induced motor response alterations in hemi-parkinsonian rats. Neuropharmacology. 47: 184-94. PMID 15223297 DOI: 10.1016/J.Neuropharm.2004.03.011  0.707
2004 Duan Y, Lipkovich I, Ahmed S, Ahl J, Hardy T, Haldane D, Baker R, Tohen M, Liu-Seifert H, Healey K, Kinon BJ, Ahmed S, Lipkovich IA, Tohen MF, Hoffmann V, ... ... Oh JD, et al. Abstracts from ASENT 2004 Annual Meeting March 11–13, 2004 Neurorx. 1: 506-514. DOI: 10.1602/Neurorx.1.4.506  0.383
2003 Bibbiani F, Oh JD, Petzer JP, Castagnoli N, Chen JF, Schwarzschild MA, Chase TN. A2A antagonist prevents dopamine agonist-induced motor complications in animal models of Parkinson's disease. Experimental Neurology. 184: 285-94. PMID 14637099 DOI: 10.1016/S0014-4886(03)00250-4  0.652
2003 Chase TN, Bibbiani F, Oh JD. Striatal glutamatergic mechanisms and extrapyramidal movement disorders. Neurotoxicity Research. 5: 139-46. PMID 12832228 DOI: 10.1007/Bf03033378  0.661
2003 Oh JD, Chartisathian K, Ahmed SM, Chase TN. Cyclic AMP responsive element binding protein phosphorylation and persistent expression of levodopa-induced response alterations in unilateral nigrostriatal 6-OHDA lesioned rats. Journal of Neuroscience Research. 72: 768-80. PMID 12774317 DOI: 10.1002/Jnr.10629  0.668
2003 Oh JD, Geller AI, Zhang Gr, Chase TN. Gene transfer of constitutively active protein kinase C into striatal neurons accelerates onset of levodopa-induced motor response alterations in parkinsonian rats. Brain Research. 971: 18-30. PMID 12691833 DOI: 10.1016/S0006-8993(03)02348-5  0.694
2002 Oh JD, Bibbiani F, Chase TN. Quetiapine attenuates levodopa-induced motor complications in rodent and primate parkinsonian models. Experimental Neurology. 177: 557-64. PMID 12429201 DOI: 10.1006/Exnr.2002.8009  0.676
2002 Oh JD, Chase TN. Glutamate-mediated striatal dysregulation and the pathogenesis of motor response complications in Parkinson's disease. Amino Acids. 23: 133-9. PMID 12373527 DOI: 10.1007/s00726-001-0118-2  0.673
2001 Oh JD. Regulation of Striatal N-Methyl-D-Aspartate Receptor (NMDAR) Function by Phosphorylation of its Subunits in Parkinsonian Rats. Methods in Molecular Medicine. 62: 247-53. PMID 21318780 DOI: 10.1385/1-59259-142-6:247  0.515
2001 Bibbiani F, Oh JD, Chase TN. Serotonin 5-HT1A agonist improves motor complications in rodent and primate parkinsonian models. Neurology. 57: 1829-34. PMID 11723272 DOI: 10.1212/Wnl.57.10.1829  0.663
2001 Chase TN, Konitsiotis S, Oh JD. Striatal molecular mechanisms and motor dysfunction in Parkinson's disease. Advances in Neurology. 86: 355-60. PMID 11553996  0.516
2000 Chase TN, Oh JD. Striatal dopamine- and glutamate-mediated dysregulation in experimental parkinsonism. Trends in Neurosciences. 23: S86-91. PMID 11052225 DOI: 10.1016/S1471-1931(00)00018-5  0.651
2000 Chase TN, Oh JD, Konitsiotis S. Antiparkinsonian and antidyskinetic activity of drugs targeting central glutamatergic mechanisms. Journal of Neurology. 247: II36-42. PMID 10991664 DOI: 10.1007/Pl00007759  0.711
2000 Chase TN, Oh JD. Striatal mechanisms and pathogenesis of parkinsonian signs and motor complications. Annals of Neurology. 47: S122-9; discussion S. PMID 10762139  0.701
2000 Oh JD, Chartisathian K, Chase TN, Butcher LL. Overexpression of neurotrophin receptor p75 contributes to the excitotoxin-induced cholinergic neuronal death in rat basal forebrain. Brain Research. 853: 174-85. PMID 10640615 DOI: 10.1016/S0006-8993(99)02054-5  0.533
1999 Oh JD, Vaughan CL, Chase TN. Effect of dopamine denervation and dopamine agonist administration on serine phosphorylation of striatal NMDA receptor subunits. Brain Research. 821: 433-42. PMID 10064831 DOI: 10.1016/S0006-8993(99)01121-X  0.68
1999 Oh JD, Russell DS, Vaughan CL, Chase TN. Corrigendum to: Enhanced tyrosine phosphorylation of striatal NMDA receptor subunits: effect of dopaminergic denervation and L-DOPA administration Brain Research. 820: 117. PMID 10023039 DOI: 10.1016/S0006-8993(99)01053-7  0.594
1998 Oh JD, Russell DS, Vaughan CL, Chase TN, Russell D. Enhanced tyrosine phosphorylation of striatal NMDA receptor subunits: effect of dopaminergic denervation and L-DOPA administration. Brain Research. 813: 150-9. PMID 9824689 DOI: 10.1016/S0006-8993(98)01049-X  0.664
1998 Chase TN, Oh JD, Blanchet PJ. Neostriatal mechanisms in Parkinson's disease. Neurology. 51: S30-5. PMID 9711978 DOI: 10.1212/Wnl.51.2_Suppl_2.S30  0.679
1997 Oh JD, Del Dotto P, Chase TN. Protein kinase A inhibitor attenuates levodopa-induced motor response alterations in the hemi-parkinsonian rat. Neuroscience Letters. 228: 5-8. PMID 9197274 DOI: 10.1016/S0304-3940(97)00355-8  0.645
Show low-probability matches.